CJC-1295 No DAC + Ipamorelin Blend

CJC-1295 (No DAC) + Ipamorelin (10mg Blend) — Growth Hormone Secretagogue Research Compound

This dual peptide blend pairs CJC-1295 (No DAC), also known as Modified GRF (1-29), with Ipamorelin — two growth hormone secretagogues that act on complementary pathways — in a single lyophilised vial containing 5mg of each. Omega Peptides Australia supplies it as a high-purity (≥99% HPLC) COA-verified powder, dispatched same day from within Australia.

Researchers looking to buy CJC-1295 and Ipamorelin in Australia get verified purity, transparent batch documentation and reliable domestic supply.

Key research areas

• Growth hormone release — studied for stimulating pulsatile GH secretion via two mechanisms
• GHRH pathway — CJC-1295 (No DAC) studied as a short-acting GHRH analog
• GH secretagogue pathway — Ipamorelin studied as a selective GH secretagogue with minimal effect on cortisol and prolactin
• Recovery & body-composition research — studied across metabolic and recovery models
• IGF-1 signalling — studied for downstream growth-factor effects

Specifications

Quality and COA verification

Every batch is independently tested by Janoshik Laboratories and supported by a Certificate of Analysis confirming identity and purity above 99%. The lyophilised format supports stability in storage and transit, and orders are packaged securely for reliable shipping across Australia.

Related research products

• CJC-1295 (DAC) 5mg — long-acting GHRH analog for comparison
• Ipamorelin 10mg — as a standalone secretagogue
• Bacteriostatic Water 10mL — for reconstitution
• Retatrutide — for multi-target research

Research guides

• CJC-1295 + Ipamorelin Research Guide
• CJC-1295 and Ipamorelin research overview
• How to store lyophilised peptides
• COA testing explained

Frequently asked questions

What is the CJC-1295 (No DAC) + Ipamorelin blend?
A dual growth hormone secretagogue research blend pairing CJC-1295 (No DAC), also known as Modified GRF (1-29), with Ipamorelin, supplied as a high-purity COA-verified lyophilised powder for laboratory research.

What is in each vial?
A total of 10mg: 5mg CJC-1295 (No DAC) and 5mg Ipamorelin.

What is the difference between No DAC and DAC?
CJC-1295 (No DAC), or Modified GRF (1-29), has a shorter activity profile than the DAC version, which carries a Drug Affinity Complex that extends its half-life in research settings.

How does the blend work?
The two peptides act on complementary pathways, CJC-1295 (No DAC) as a GHRH analog and Ipamorelin as a selective GH secretagogue, studied together for their combined effect on growth hormone release.

How do you reconstitute it?
Reconstitute with bacteriostatic water immediately before use. Add the water slowly down the inside wall of the vial and swirl gently, do not shake. Store the reconstituted solution at 2–8°C and use within 28 days.

How should it be stored?
Store the lyophilised vial at 2–8°C away from light and moisture, and avoid repeated freeze-thaw cycles. After reconstitution, keep refrigerated at 2–8°C and use within 28 days.

Where can I buy CJC-1295 and Ipamorelin in Australia?
Directly from Omega Peptides Australia, dispatched domestically with same-day dispatch on orders before 12pm and batch CoAs available in our library.

Is it legal in Australia?
Omega Peptides Australia supplies this blend strictly for lawful in-vitro laboratory research. It is not approved by the TGA for human or veterinary use and is not sold as a medicine or supplement. Purchasers are responsible for ensuring their intended use complies with all applicable laws.

What is the cost and availability?
The CJC-1295 (No DAC) + Ipamorelin blend (10mg) is in stock at $139.99 per vial, dispatched domestically across Australia, with batch CoAs available in our library.

⚠ For in-vitro research and laboratory use only. Not for human or veterinary use.